Commonwealth Equity Services, LLC United Therapeutics Corp Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 8,225 shares of UTHR stock, worth $2.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,225

Previous 6,851 20.06%

Holding current value

$2.97 Million

Previous $2.18 Million 35.06%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$311.04 - $363.55 $427,368 - $499,517	1,374 Added 20.06%	8,225 $2.95 Million
Q2 2024 Jul 31, 2024	BUY	$228.26 - $319.04 $447,161 - $624,999	1,959 Added 40.04%	6,851 $2.18 Million
Q1 2024 Apr 29, 2024	SELL	$210.76 - $249.51 $78,824 - $93,316	-374 Reduced 7.1%	4,892 $1.12 Million
Q4 2023 Feb 06, 2024	BUY	$214.88 - $256.94 $14,396 - $17,214	67 Added 1.29%	5,266 $1.16 Million
Q3 2023 Oct 23, 2023	SELL	$211.82 - $248.24 $6,778 - $7,943	-32 Reduced 0.61%	5,199 $1.17 Million
Q2 2023 Aug 10, 2023	SELL	$205.19 - $232.99 $26,674 - $30,288	-130 Reduced 2.42%	5,231 $1.16 Million
Q1 2023 May 11, 2023	BUY	$212.99 - $276.17 $63,684 - $82,574	299 Added 5.91%	5,361 $1.2 Million
Q4 2022 Feb 07, 2023	SELL	$205.95 - $280.43 $7,826 - $10,656	-38 Reduced 0.75%	5,062 $1.41 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $52,044 - $62,507	256 Added 5.28%	5,100 $1.07 Million
Q2 2022 Jul 19, 2022	BUY	$174.81 - $241.14 $39,681 - $54,738	227 Added 4.92%	4,844 $1.14 Million
Q1 2022 May 04, 2022	SELL	$166.16 - $213.96 $9,471 - $12,195	-57 Reduced 1.22%	4,617 $828,000
Q4 2021 Jan 31, 2022	BUY	$184.32 - $216.08 $8,110 - $9,507	44 Added 0.95%	4,674 $1.01 Million
Q3 2021 Oct 29, 2021	BUY	$179.86 - $214.88 $7,194 - $8,595	40 Added 0.87%	4,630 $854,000
Q2 2021 Aug 11, 2021	SELL	$170.47 - $211.93 $5,966 - $7,417	-35 Reduced 0.76%	4,590 $823,000
Q1 2021 May 04, 2021	SELL	$153.94 - $174.85 $29,864 - $33,920	-194 Reduced 4.03%	4,625 $773,000
Q4 2020 Feb 11, 2021	SELL	$101.87 - $151.79 $149,748 - $223,131	-1,470 Reduced 23.37%	4,819 $731,000
Q3 2020 Nov 05, 2020	BUY	$99.9 - $121.13 $347,352 - $421,169	3,477 Added 123.65%	6,289 $635,000
Q2 2020 Aug 12, 2020	SELL	$92.74 - $125.82 $7,419 - $10,065	-80 Reduced 2.77%	2,812 $340,000
Q1 2020 May 11, 2020	SELL	$79.39 - $115.35 $20,006 - $29,068	-252 Reduced 8.02%	2,892 $274,000
Q4 2019 Feb 05, 2020	BUY	$78.31 - $95.34 $246,206 - $299,748	3,144 New	3,144 $276,000

Others Institutions Holding UTHR

# of Institutions

671

Shares Held

42.3M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC United Therapeutics Corp Transaction History